607 related articles for article (PubMed ID: 33005286)
21. Oral immunotherapy for multiple foods in a pediatric allergy clinic setting.
Eapen AA; Lavery WJ; Siddiqui JS; Lierl MB
Ann Allergy Asthma Immunol; 2019 Dec; 123(6):573-581.e3. PubMed ID: 31494236
[TBL] [Abstract][Full Text] [Related]
22. Advances in the management of peanut allergy (oral immunotherapy and epicutaneous immunotherapy).
Wang J
Allergy Asthma Proc; 2020 Jan; 41(1):5-9. PubMed ID: 31888777
[No Abstract] [Full Text] [Related]
23. Immunotherapy in food allergy: towards new strategies.
Sato S; Yanagida N; Ogura K; Asaumi T; Okada Y; Koike Y; Iikura K; Syukuya A; Ebisawa M
Asian Pac J Allergy Immunol; 2014 Sep; 32(3):195-202. PubMed ID: 25268336
[TBL] [Abstract][Full Text] [Related]
24. Oral immunotherapy using boiled peanuts for treating peanut allergy: An open-label, single-arm trial.
Grzeskowiak LE; Tao B; Aliakbari K; Chegeni N; Morris S; Chataway T
Clin Exp Allergy; 2023 Mar; 53(3):327-336. PubMed ID: 36628520
[TBL] [Abstract][Full Text] [Related]
25. Oral Immunotherapy for Food-Allergic Children: A Pro-Con Debate.
Mori F; Giovannini M; Barni S; Jiménez-Saiz R; Munblit D; Biagioni B; Liccioli G; Sarti L; Liotti L; Ricci S; Novembre E; Sahiner U; Baldo E; Caimmi D
Front Immunol; 2021; 12():636612. PubMed ID: 34650547
[TBL] [Abstract][Full Text] [Related]
26. Oral and sublingual immunotherapy for egg allergy.
Romantsik O; Bruschettini M; Tosca MA; Zappettini S; Della Casa Alberighi O; Calevo MG
Cochrane Database Syst Rev; 2014 Nov; (11):CD010638. PubMed ID: 25405335
[TBL] [Abstract][Full Text] [Related]
27. Changes in patient quality of life during oral immunotherapy for food allergy.
Rigbi NE; Goldberg MR; Levy MB; Nachshon L; Golobov K; Elizur A
Allergy; 2017 Dec; 72(12):1883-1890. PubMed ID: 28542911
[TBL] [Abstract][Full Text] [Related]
28. Peanut (
Casale TB; Irani AM
Expert Rev Clin Immunol; 2023 Mar; 19(3):253-265. PubMed ID: 36524617
[TBL] [Abstract][Full Text] [Related]
29. Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects.
Otani IM; Bégin P; Kearney C; Dominguez TL; Mehrotra A; Bacal LR; Wilson S; Nadeau K
Allergy Asthma Clin Immunol; 2014; 10(1):25. PubMed ID: 24860608
[TBL] [Abstract][Full Text] [Related]
30. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy.
Pajno GB; Fernandez-Rivas M; Arasi S; Roberts G; Akdis CA; Alvaro-Lozano M; Beyer K; Bindslev-Jensen C; Burks W; Ebisawa M; Eigenmann P; Knol E; Nadeau KC; Poulsen LK; van Ree R; Santos AF; du Toit G; Dhami S; Nurmatov U; Boloh Y; Makela M; O'Mahony L; Papadopoulos N; Sackesen C; Agache I; Angier E; Halken S; Jutel M; Lau S; Pfaar O; Ryan D; Sturm G; Varga EM; van Wijk RG; Sheikh A; Muraro A;
Allergy; 2018 Apr; 73(4):799-815. PubMed ID: 29205393
[TBL] [Abstract][Full Text] [Related]
31. A Practical, Stepwise Approach to Peanut Oral Immunotherapy in Clinical Practice: Benefits and Risks.
Anagnostou A
J Asthma Allergy; 2021; 14():277-285. PubMed ID: 33790583
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
O'B Hourihane J; Beyer K; Abbas A; Fernández-Rivas M; Turner PJ; Blumchen K; Nilsson C; Ibáñez MD; Deschildre A; Muraro A; Sharma V; Erlewyn-Lajeunesse M; Zubeldia JM; De Blay F; Sauvage CD; Byrne A; Chapman J; Boralevi F; DunnGalvin A; O'Neill C; Norval D; Vereda A; Skeel B; Adelman DC; du Toit G
Lancet Child Adolesc Health; 2020 Oct; 4(10):728-739. PubMed ID: 32702315
[TBL] [Abstract][Full Text] [Related]
33. Peanut oral immunotherapy: is it ready for clinical practice?
Sampson HA
J Allergy Clin Immunol Pract; 2013 Jan; 1(1):15-21. PubMed ID: 24229817
[TBL] [Abstract][Full Text] [Related]
34. Oral and sublingual peanut immunotherapy is not ready for general use.
Greenhawt MJ
Allergy Asthma Proc; 2013; 34(3):197-204. PubMed ID: 23676568
[TBL] [Abstract][Full Text] [Related]
35. Oral Immunotherapy (OIT): A Personalized Medicine.
Mori F; Barni S; Liccioli G; Novembre E
Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31614929
[TBL] [Abstract][Full Text] [Related]
36. Peanut Oral Immunotherapy: a Current Perspective.
Patrawala M; Shih J; Lee G; Vickery B
Curr Allergy Asthma Rep; 2020 Apr; 20(5):14. PubMed ID: 32314071
[TBL] [Abstract][Full Text] [Related]
37. Changing Patient Mindsets about Non-Life-Threatening Symptoms During Oral Immunotherapy: A Randomized Clinical Trial.
Howe LC; Leibowitz KA; Perry MA; Bitler JM; Block W; Kaptchuk TJ; Nadeau KC; Crum AJ
J Allergy Clin Immunol Pract; 2019; 7(5):1550-1559. PubMed ID: 30682576
[TBL] [Abstract][Full Text] [Related]
38. Improving the safety of oral immunotherapy for food allergy.
Vazquez-Ortiz M; Turner PJ
Pediatr Allergy Immunol; 2016 Mar; 27(2):117-25. PubMed ID: 26593873
[TBL] [Abstract][Full Text] [Related]
39. Eosinophilic Esophagitis as a Side Effect of Food Oral Immunotherapy.
Cianferoni A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33207848
[TBL] [Abstract][Full Text] [Related]
40. Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.
Bégin P; Winterroth LC; Dominguez T; Wilson SP; Bacal L; Mehrotra A; Kausch B; Trela A; Hoyte E; O'Riordan G; Seki S; Blakemore A; Woch M; Hamilton RG; Nadeau KC
Allergy Asthma Clin Immunol; 2014 Jan; 10(1):1. PubMed ID: 24428859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
